GBIO
Price
$0.39
Change
-$0.01 (-2.50%)
Updated
Jun 4 closing price
Capitalization
25.97M
62 days until earnings call
XOMA
Price
$24.82
Change
-$0.18 (-0.72%)
Updated
Jun 5, 11:40 AM (EDT)
Capitalization
299.17M
62 days until earnings call
Interact to see
Advertisement

GBIO vs XOMA

Header iconGBIO vs XOMA Comparison
Open Charts GBIO vs XOMABanner chart's image
Generation Bio
Price$0.39
Change-$0.01 (-2.50%)
Volume$554.27K
Capitalization25.97M
XOMA Royalty
Price$24.82
Change-$0.18 (-0.72%)
Volume$100
Capitalization299.17M
GBIO vs XOMA Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. XOMA commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and XOMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (GBIO: $0.39 vs. XOMA: $25.00)
Brand notoriety: GBIO and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 108% vs. XOMA: 104%
Market capitalization -- GBIO: $25.97M vs. XOMA: $299.17M
GBIO [@Biotechnology] is valued at $25.97M. XOMA’s [@Biotechnology] market capitalization is $299.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while XOMA’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 3 bearish.
  • XOMA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than XOMA.

Price Growth

GBIO (@Biotechnology) experienced а +5.67% price change this week, while XOMA (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.92%. For the same industry, the average monthly price growth was +10.77%, and the average quarterly price growth was -1.68%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

XOMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($299M) has a higher market cap than GBIO($26M). XOMA YTD gains are higher at: -4.871 vs. GBIO (-63.453). XOMA has higher annual earnings (EBITDA): -18.71M vs. GBIO (-69.2M). GBIO has more cash in the bank: 158M vs. XOMA (143M). GBIO has less debt than XOMA: GBIO (87.6M) vs XOMA (119M). GBIO has higher revenues than XOMA: GBIO (24.6M) vs XOMA (9.71M).
GBIOXOMAGBIO / XOMA
Capitalization26M299M9%
EBITDA-69.2M-18.71M370%
Gain YTD-63.453-4.8711,303%
P/E RatioN/AN/A-
Revenue24.6M9.71M253%
Total Cash158M143M110%
Total Debt87.6M119M74%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOXOMA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEUP7.150.30
+4.38%
Neuphoria Therapeutics Inc
CARS10.420.06
+0.58%
Cars.com
NRGV0.91-0.01
-0.59%
Energy Vault Holdings
ED102.21-1.03
-1.00%
Consolidated Edison
AQN5.92-0.30
-4.82%
Algonquin Power & Utilities Corp

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-2.86%
CCCC - GBIO
48%
Loosely correlated
+4.05%
FHTX - GBIO
46%
Loosely correlated
-3.67%
ATNM - GBIO
46%
Loosely correlated
+1.79%
IDYA - GBIO
46%
Loosely correlated
-2.50%
ABOS - GBIO
45%
Loosely correlated
+2.88%
More